Molecular modelling studies of new potential human DNA polymerase α inhibitors

6Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The human polymerase α (pol α) is a promising target for the therapy of cancer e.g. of the skin. The authors recently built a homology model of the active site of human DNA pol α. This 3D model was now used for molecular modelling studies with eight novel analogues of 2-butylanilino-dATP, which is a highly selective nucleoside inhibitor of mammalian pol α. Our results suggest that a higher hydrophobicity of a carbohydrate side chain (pointing into a spacious hydrophobic cavity) may enhance the strength of the interaction with the target protein. Moreover, acyclic acyclovir-like derivatives outperformed those with a sugar-moiety, indicating that structural flexibility and higher conformational adaptability has a positive effect on the receptor affinity. Cytotoxicity tests confirmed our theoretical findings. Besides, one of our most promising compounds in the molecular modelling studies revealed high selectivity for the SCC-25 cell line derived from squamous cell carcinoma in man. © 2011 Informa UK, Ltd.

Cite

CITATION STYLE

APA

Zdrazil, B., Schwanke, A., Schmitz, B., Schäfer-Korting, M., & Höltje, H. D. (2011). Molecular modelling studies of new potential human DNA polymerase α inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry, 26(2), 270–279. https://doi.org/10.3109/14756366.2010.503609

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free